Skip to main content

TD Asset Management Inc

Position in NBIX — Neurocrine Biosciences Inc

CIK 1056053 Toronto, A6

Position in NBIX

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$5,894,349
+$1,339,702 QoQ
Shares Held
34,973
+1.2% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#196
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $359,418,700 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NBIX
Neurocrine Biosciences Inc
This page
34,973 $5,894,349

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,894,349 34,973
2026-03-31 $4,554,647 34,573
2025-12-31 $10,080,283 71,073
2025-09-30 $14,546,596 103,623
2025-06-30 $15,500,467 123,323
2025-03-31 $13,624,039 123,183
2024-12-31 $13,893,379 101,783
2024-09-30 $13,687,329 118,793
2024-06-30 $19,310,557 140,267
2024-03-31 $19,782,417 143,434
2023-12-31 $13,731,895 104,219
2023-09-30 $6,266,025 55,698
2023-06-30 $3,332,373 35,338
2023-03-31 $3,734,613 36,896
2022-12-31 $4,557,591 38,158
2022-09-30 $14,620,018 137,652
2022-06-30 $22,747,152 233,352
2022-03-31 $25,446,937 271,434
2021-12-31 $24,173,715 283,829
2021-09-30 $15,473,543 161,334
2021-06-30 $16,722,884 171,834
2021-03-31 $18,972,016 195,085
2020-12-31 $17,267,856 180,155
2020-09-30 $16,750,975 174,199
2020-06-30 $20,337,156 166,698
2020-03-31 $12,753,748 147,357